Key Points

  • After a slow spring, investment firms of the ultra-rich made 60 direct investments in June, according to Fintrx.
  • Family offices flocked to biotech and health-care firms such as Antheia, seeking to make an impact and returns at the same time.
  • Antheia founder Christina Smolke told CNBC’s Inside Wealth family offices’ patient capital makes them a good fit for investing in scientific breakthroughs.



Source link

Share.
Leave A Reply

Exit mobile version